1zs0

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1zs0" size="450" color="white" frame="true" align="right" spinBox="true" caption="1zs0, resolution 1.56&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:1zs0.gif|left|200px]]<br />
+
[[Image:1zs0.gif|left|200px]]<br /><applet load="1zs0" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1zs0" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1zs0, resolution 1.56&Aring;" />
caption="1zs0, resolution 1.56&Aring;" />
'''Crystal structure of the complex between MMP-8 and a phosphonate inhibitor (S-enantiomer)'''<br />
'''Crystal structure of the complex between MMP-8 and a phosphonate inhibitor (S-enantiomer)'''<br />
==Overview==
==Overview==
-
Potent and selective inhibitors of matrix metalloproteinases (MMPs), a, family of zinc proteases that can degrade all the components of the, extracellular matrix, could be useful for treatment of diseases such as, cancer and arthritis. The most potent MMP inhibitors are based on, hydroxamate as zinc-binding group (ZBG). alpha-Arylsulfonylamino, phosphonates incorporate a particularly favorable combination of, phosphonate as ZBG and arylsulfonylamino backbone so that their affinity, exceptionally attains the nanomolar strength frequently observed for, hydroxamate analogues. The detailed mode of binding of, [1-(4'-methoxybiphenyl-4-sulfonylamino)-2-methylpropyl]phosphonate has, been clarified by the crystal structures of the complexes that the R- and, S-enantiomers respectively form with MMP-8. The reasons for the, preferential MMP-8 inhibition by the R-phosphonate are underlined and the, differences in the mode of binding of analogous alpha-arylsulfonylamino, hydroxamates and carboxylates are discussed.
+
Potent and selective inhibitors of matrix metalloproteinases (MMPs), a family of zinc proteases that can degrade all the components of the extracellular matrix, could be useful for treatment of diseases such as cancer and arthritis. The most potent MMP inhibitors are based on hydroxamate as zinc-binding group (ZBG). alpha-Arylsulfonylamino phosphonates incorporate a particularly favorable combination of phosphonate as ZBG and arylsulfonylamino backbone so that their affinity exceptionally attains the nanomolar strength frequently observed for hydroxamate analogues. The detailed mode of binding of [1-(4'-methoxybiphenyl-4-sulfonylamino)-2-methylpropyl]phosphonate has been clarified by the crystal structures of the complexes that the R- and S-enantiomers respectively form with MMP-8. The reasons for the preferential MMP-8 inhibition by the R-phosphonate are underlined and the differences in the mode of binding of analogous alpha-arylsulfonylamino hydroxamates and carboxylates are discussed.
==About this Structure==
==About this Structure==
-
1ZS0 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CA, ZN, EIN and MES as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Neutrophil_collagenase Neutrophil collagenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.34 3.4.24.34] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1ZS0 OCA].
+
1ZS0 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CA:'>CA</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=EIN:'>EIN</scene> and <scene name='pdbligand=MES:'>MES</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Neutrophil_collagenase Neutrophil collagenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.34 3.4.24.34] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ZS0 OCA].
==Reference==
==Reference==
Line 25: Line 24:
[[Category: Tortorella, P.]]
[[Category: Tortorella, P.]]
[[Category: Tschesche, H.]]
[[Category: Tschesche, H.]]
-
[[Category: Tucker, P.A.]]
+
[[Category: Tucker, P A.]]
[[Category: CA]]
[[Category: CA]]
[[Category: EIN]]
[[Category: EIN]]
Line 34: Line 33:
[[Category: sulphonamide junction]]
[[Category: sulphonamide junction]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:39:59 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:18:32 2008''

Revision as of 14:18, 21 February 2008


1zs0, resolution 1.56Å

Drag the structure with the mouse to rotate

Crystal structure of the complex between MMP-8 and a phosphonate inhibitor (S-enantiomer)

Overview

Potent and selective inhibitors of matrix metalloproteinases (MMPs), a family of zinc proteases that can degrade all the components of the extracellular matrix, could be useful for treatment of diseases such as cancer and arthritis. The most potent MMP inhibitors are based on hydroxamate as zinc-binding group (ZBG). alpha-Arylsulfonylamino phosphonates incorporate a particularly favorable combination of phosphonate as ZBG and arylsulfonylamino backbone so that their affinity exceptionally attains the nanomolar strength frequently observed for hydroxamate analogues. The detailed mode of binding of [1-(4'-methoxybiphenyl-4-sulfonylamino)-2-methylpropyl]phosphonate has been clarified by the crystal structures of the complexes that the R- and S-enantiomers respectively form with MMP-8. The reasons for the preferential MMP-8 inhibition by the R-phosphonate are underlined and the differences in the mode of binding of analogous alpha-arylsulfonylamino hydroxamates and carboxylates are discussed.

About this Structure

1ZS0 is a Single protein structure of sequence from Homo sapiens with , , and as ligands. Active as Neutrophil collagenase, with EC number 3.4.24.34 Full crystallographic information is available from OCA.

Reference

Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates., Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F, J Med Chem. 2006 Feb 9;49(3):923-31. PMID:16451058

Page seeded by OCA on Thu Feb 21 16:18:32 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools